05 Compliance

The regulatory file for nervonic acid

Technical document 05 · Reviewed 2026-11-19 · Nervonic Acid

On this page
  1. What has to line up
  2. European Union
  3. United States
  4. Great Britain and Northern Ireland
  5. Contaminants and the finished-product calculation
  6. The claims boundary
  7. Documents in the pack
  8. Checklist before the first order

Nervonic acid is supplied as a free fatty acid, CAS 506-37-6, with a C24:1 minimum of ≥90.0% by GC. A specification tells a buyer what the powder is; it does not tell anyone whether that powder can be sold in a given market. The route, the limits and the label wording have to be worked out for the destination and the dose, and that work belongs to the buyer’s regulatory team. What follows is a checklist of the frameworks, the limits, the claims line and the documents to collect.

In one line

A specification proves what the powder is; the regulatory file proves that this material can be sold where the buyer intends to sell it.

What has to line up

Four things have to line up before a file is complete. First, the material: which specification revision, which form, and which seed oil it was fractionated from. Second, the lot: what its certificate reports and which code it carries. Third, the market: the limits, the label and the route that apply where the product will be sold. Fourth, the change: what happens to the file when the source, the process or the pack itself moves. The certificate covers the second, the data sheet covers the first, and the safety data sheet covers handling; none of them settles the market question on its own.

A high-purity fatty acid is not automatically the same regulatory object as the oil it was fractionated from. The enrichment step changes the composition, so a source oil that has a history of use does not by itself establish a route for a 90% free acid. The file should name the material as it is bought, not as the oil it came from, and every document in it should carry a version or a date.

European Union

In the EU, a food with no significant history of consumption before 15 May 1997 falls under the novel food framework, Regulation (EU) 2015/2283. The buyer’s regulatory team confirms whether the exact material needs an authorisation and whether it appears on the Union list; that question is about the material and the use level, not about the seed oil. Food supplements are otherwise governed by Directive 2002/46/EC, which harmonises vitamins and minerals, while substances outside that list remain a member-state competence. Contaminants fall under Commission Regulation (EU) 2023/915, labelling under Regulation (EU) 1169/2011 and claims under Regulation (EC) 1924/2006. Check the current consolidated text for each, as of this review.

United States

In the United States, the route is a dietary ingredient documented in use before 15 October 1994, or a notification for a new dietary ingredient filed under 21 CFR 190.6 at least 75 days before marketing; a food use is a separate question, usually answered through the GRAS route. The supplier can state which basis it holds and point to the supporting document. It is the buyer who decides whether that basis reaches the finished product and the wording on the pack. Labelling follows 21 CFR 101, and a structure or function claim carries the disclaimer required by 21 CFR 101.93.

Great Britain and Northern Ireland

Two regimes, not one. Great Britain runs its own novel food register and labelling rules, while Northern Ireland applies the EU framework. The buyer’s team records which one covers the destination, and that note stays with the order.

Contaminants and the finished-product calculation

Contaminants are judged on the supplement as eaten, so the arithmetic runs from the drum to the daily dose. The catalog limits below are release gates for the ingredient; the destination rules apply to the finished product.

Ingredient limits to carry into the finished-product file
ParameterCatalog limitWhat the finished-product file needs
Lead (Pb)≤3 mg/kgThe lot result and the calculation to the daily dose
Arsenic (As)≤2 mg/kgThe method, the limit and the destination rule
Cadmium (Cd)≤1 mg/kgThe lot result, plus any exception that applies to the category
Mercury (Hg)≤0.1 mg/kgThe lot result and the method
Oxidation (PV, AV)Agreed per orderThe agreed limits and the results on the lot
C24:1 and cis/trans≥90.0%, profile reportedThe GC result, the column and the isomer statement

The claims boundary

The page, the label and the sales material carry no disease-related claim. That includes the wording around memory, nerve tissue and myelin: nervonic acid is a normal component of the sphingolipids of nerve tissue, which is a compositional fact, but a label that uses the fact to imply a benefit is a health claim in the EU and a structure or function claim in the United States, and neither is available without the supporting authorisation or the notification route.

Nervonic acid is also not an essential fatty acid. The body elongates oleic acid to C24:1, so an “essential fatty acid” line would be inaccurate as well as unavailable as a claim. The 90% figure is a specification, not a health claim, and the monounsaturated fat in the nutrition declaration refers to the food rather than to a permitted claim about this ingredient.

Documents in the pack

  • A lot certificate that lists the method, the limit and the result for each line.
  • The data sheet, plus the revision of the specification that the order references.
  • A safety data sheet that names the storage condition and the melting range.
  • Allergen statement: if the lot came from macadamia, the source is a tree nut on the EU Annex II list, while the US major-allergen definition provides a refining exemption; the buyer applies the destination rule to the actual material.
  • Statements on GMO status, origin, residual solvent and the cis/trans ratio.
  • The fatty-acid profile, the acid value and the oxidation results for the lot.

Checklist before the first order

  • The material, CAS number and free-acid form are named on every document.
  • The assay basis and the ester factor are written into the specification.
  • The buyer’s regulatory team has put the route decision in writing.
  • The source seed oil and the allergen statement match the lot.
  • Metal results have been recalculated to the daily dose.
  • The label wording and any claim have had a market review.
  • Change control covers the source, the process and the pack.

The catalog gate is published on the product hub; the lot evidence is explained on the COA page; the analytical identity is on the identity page; the framework notes are in the EU, US and UK references; the release paperwork is described on the quality page.

Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.

Request a quotation